Medical/Pharmaceuticals

United Imaging and HKSH Medical Group Establish Strategic Partnership to Elevate Imaging Excellence

HONG KONG, May 27, 2025 /PRNewswire/ -- United Imaging and HKSH Medical Group announced on Monday the signing of a Memorandum of Understanding (MOU), marking a significant step forward in fostering innovation and shared commitment. The signing ceremony was held during the Asia Summit Global Healt...

2025-05-27 19:15 2036

RemeGen: Telitacicept for the Treatment of Generalized Myasthenia Gravis Approved in China

YANTAI, China, May 27, 2025 /PRNewswire/ -- On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of adult patients with anti-acetylcholine recepto...

2025-05-27 16:30 2330

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

The next-generation skin analysis platform, set to redefine the aesthetic consultation experience CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launchedA...

2025-05-27 13:00 2251

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval inIndonesia. This marks the ZYLOX Unicorn™ Vascular Cl...

2025-05-27 10:14 3003

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

The next-generation skin analysis platform, set to redefine the aesthetic consultation experience CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launchedA...

2025-05-27 07:00 2153

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

SAN DIEGO, May 26, 2025 /PRNewswire/ -- A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare®, a novel, non-invasive multi-omics blood test designed for the early detection of multiple cancer types. Developed by research...

2025-05-26 23:00 2466

May 19: World Inflammatory Bowel Disease Day | Healthy Gut, Happy Life

SHENZHEN, China, May 26, 2025 /PRNewswire/ -- May 19 is designated as World Inflammatory Bowel Disease (IBD) Day, aimed at raising public awareness of IBD patients and improving their quality of life and medical care. The European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA),...

2025-05-26 21:24 2696

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) ...

2025-05-26 21:00 2291

MGI Tech Showcases Comprehensive Multi-Omics Solutions at ESHG 2025 Milan

MILAN, May 26, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, unveiled cutting-edge multi-omics technologies at the European Society of Human Genetics (ESHG) 2025 conference inMilan. At Booth #31...

2025-05-26 18:30 1900

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with ORR of 84.2% * DZD6008, a BBB-penetrant 4th generation EGFR TKI, showed encouraging and durable anti-tumor activity with favorable safet...

2025-05-26 18:06 2278

Esaote: The new MyLab™Heron ultrasound scanner for veterinary physicians had its world premiere at the SCIVAC Rimini 2025 Congress

GENOA, Italy, May 26, 2025 /PRNewswire/ -- Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heronultrasound system at the Congress organized in Rimini from May 23 to 25 Mayby SCIVAC, the largest Veterinary Scientific Society in...

2025-05-26 18:00 2349

VUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction

– Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ -- VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 National Teaching Institute & Critical Care Exposition (N...

2025-05-26 13:50 2269

Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC

SHANGHAI, May 26, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the Chi...

2025-05-26 12:15 4021

World's First -- XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical Trial

SUZHOU, China, May 25, 2025 /PRNewswire/ -- In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy has received official approval from bothChina's N...

2025-05-26 09:00 2337

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-26 08:00 3673

EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled "China's Medical Techno...

2025-05-25 21:41 3269

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray  (SZSE: 300760), a leading global developer of healthcare technologies, launched itsBeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this ad...

2025-05-25 19:00 3420

Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...

2025-05-24 01:47 4399

/DISREGARD RELEASE: Celltrion/

We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...

2025-05-24 00:01 4372

Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...

2025-05-23 22:00 4367
1 ... 91929394959697 ... 645

Week's Top Stories